https://www.selleckchem.com/
Understanding how brassinosteroid and immune signalling pathways are integrated in plants will help develop strategies to minimize the growth-defence trade-off, a key challenge for crop improvement. The cost-effectiveness of antiviral treatment in adult immune-tolerant (IT) phase chronic hepatitis B (CH patients is uncertain. We designed a Markov model to compare expected costs and quality-adjusted life-years (QALYs) of starting antiviral treatment at IT-phase ('treat-IT' vs delaying the therapy until active hepatitis phase ('untreat-IT' in CHB patients
Like
Comment
Share
